AbsEn.i
Curation
Istex
Racine
Curation
Checkpoint
Istex
Racine
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « sat »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
sasebo < sat < satisfaction  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 126.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000350 (2013) G. Horneff ; N. Onken ; A. Hospach [Allemagne] ; G. Ganser ; H. I. Huppertz [Allemagne]SAT0462 Experience with Tocilizumab in 29 Patients with Systemic Onset Juvenile Idiopathic Arthritis
000375 (2013) G. Horneff ; S. Nimmrich [Allemagne]SAT0463 Incidence of Herpes Zoster Infections in Juvenile Idiopathic Arthritis Patients – Experience of the Biker Registry
000387 (2013) R. Denisova ; E. Alekseeva [Russie] ; S. Valieva ; T. Bzarova ; K. Isayeva ; T. Sleptsova ; E. Mitenko ; E. Chistyakova [Russie] ; A. FetisovaSAT0445 Survival of Tocilizumab Therapy in Children with Systemic Juvenile Idiopathic Arthritis. Russian Experience
000404 (2013) M. Hirao ; H. Tsuboi ; S. Akita ; K. Ebina ; M. Matsushita ; S. Ohshima ; Y. Saeki ; N. Nishimoto [Japon] ; J. HashimotoSAT0113 Intense Repression of Serum Oxidative Stress Marker in Rheumatoid Arthritis Cases Treated with Tocilizumab: Cross Sectional and Longitudinal Evaluation
000406 (2013) E. Alekseeva [Russie] ; R. Denisova ; S. Valieva ; T. Bzarova ; K. Isayeva ; T. Sleptsova ; E. Mitenko ; E. Chistyakova [Russie] ; A. FetisovaSAT0459 Tocilizumab Therapy in Children with Systemic Juvenile Idiopathic Arthritis. Russian Experience
000409 (2013) T. Kasama [Japon] ; M. Umemura [Japon] ; S. Isojima [Japon] ; T. Tokunaga [Japon] ; H. Tsukamoto [Japon] ; R. Yanai [Japon] ; H. Furuya [Japon] ; Y. Miwa [Japon]SAT0141 Correlation of Serum Macrophage Migration Inhibitory Factor Levels With Response to Tocilizumab Therapy in Patients with Rheumatoid Arthritis
000448 (2013) G. Almanzar [Allemagne] ; K. Sustal [Allemagne] ; R. Trippen [Allemagne] ; K. Höfner [Allemagne] ; M. Prelog [Allemagne]SAT0464 Disease Status Influences the Balance and Cytokine Profile in Patients with Juvenile Idiopathic Arthritis
000451 (2013) T. Kojima [Japon] ; N. Takahashi [Japon] ; K. Funahashi [Japon] ; D. Kato [Japon] ; Y. Hattori [Japon] ; M. Hanabayashi [Japon] ; N. Asai [Japon] ; N. Ishiguro [Japon]SAT0139 Importance of Concomitant MTX Use During Treatment with Tocilizumab in Patients with Rheumatoid Arthritis
000459 (2013) N. Mozaffarian [États-Unis] ; M. Karunaratne [États-Unis] ; V. Arora [États-Unis]SAT0444 Administration of Routine Preventative Vaccinations in Children with Juvenile Idiopathic Arthritis Receiving Adalimumab
000504 (2013) M. A. Cimmino ; P. Sarzi-Puttini ; S. Bombardieri [Italie] ; A. Iagnocco [Italie] ; L. Sinigaglia ; F. Debenedetti [Italie]SAT0114 Effects Of Tocilizumab (TCZ) in Combination with Non-Biologic Dmards in the Inhibition of Progression of Synovitis, Bone Marrow Edema and Erosions Evaluated by Extremity-Dedicated Magnetic Resonance Imaging (MRI) In Rheumatoid Arthritis (RA)
000506 (2013) H. Sanner ; I. Sjaastad [Norvège] ; B. FlatSAT0465 The Myositis Disease Activity Assessment Tool and the Printo Criteria for Clinically Inactive Disease Applied after Long-Term Follow-Up in Juvenile Onset Dermatomyositis.
000556 (2013) Y. Yabe [Japon] ; T. Kojima ; A. Kaneko ; Y. Kanayama ; Y. Hirano ; T. Shioura ; K. Saito [Japon] ; N. Asai ; T. Kobayakawa ; N. IshiguroSAT0143 Analysis of Patients Who Obtained Remission by Disease Activity Score After Tocilizumab Treatment But Still had Low Disease Activity by Clinical Disease Activity Index, and Examination of Points for Treatment Intensification
000581 (2013) T. Takeuchi [Japon] ; Y. Tanaka ; K. Amano ; J. Kikuchi [Japon] ; E. Tanaka [Japon] ; S. Hirata ; H. Nagasawa ; H. Yasuoka [Japon] ; H. Yamanaka [Japon]SAT0140 Effectiveness of Abatacept Against Rheumatoid Arthritis in Daily Clinical Practice - Orbit Study
000614 (2013) G. R. Burmester [Allemagne] ; A. Rubbert-Roth [Allemagne] ; A. Cantagrel [France] ; S. Hall [Australie] ; P. Leszczynski [Pologne] ; D. Feldman [Brésil] ; M. J. Rangaraj ; G. Roane ; C. Ludivico [États-Unis] ; E. Mysler [Argentine] ; L. Rowell [Royaume-Uni] ; I. Vranic [Royaume-Uni]SAT0105 Summacta: A Randomized, Double-Blind, Parallel Group Study of the Safety and Efficacy Of Tocilizumab SC Versus Tocilizumab IV, in Combination with Traditional Dmards in Patients With Moderate to Severe Ra
000625 (2013) K. Minden ; M. Niewerth [Allemagne] ; G. Horneff ; A. Thon ; G. Ganser ; I. Foeldvari [Allemagne] ; J. KlotscheSAT0443 Changes in Treatment and Outcomes of Patients with Polyarticular Juvenile Idiopathic Arthritis (PJIA)
000630 (2013) T. Okano ; T. Koike [Japon] ; M. Tada ; Y. Sugioka ; K. Mamoto ; K. Inui ; H. NakamuraSAT0138 Prediction of Response to Tocilizumab Using Biomarkers (Interleukin-1 Beta, D-Dimer and Fibrinogen) in Patients with Rheumatoid Arthritis
000641 (2013) E. Alekseeva [Russie] ; T. Bzarova ; A. Fetisova ; S. Valieva ; K. Isayeva ; R. Denisova ; T. Sleptsova ; E. Mitenko ; E. Chistyakova [Russie]SAT0457 Efficacy and Safety of Etanercept in Combination with Methotrexate in the Patients with Early and Late Juvenile Idiopathic Arthritis
000642 (2013) F. A. Aeschlimann ; K. D. Hofer ; E. Cannizzaro ; S. Schroeder ; R. Lauener ; R. K. Saurenmann [Suisse]SAT0461 Infliximab Treatment in Children: Frequency of Infusion Reactions and Role of Desensitization
000652 (2013) D. Dimopoulou ; M. Trachana ; P. Sidiropoulos ; P. Tsitsi ; A. Moihovitou [Grèce] ; A. GaryfallosSAT0456 Long-Term Outcome in Adult Patients with Juvenile Idiopathic Arthritis: Preliminary Results from a Greek Population
000654 (2013) U. Klein [Suisse] ; E. Liang [Suisse] ; B. Vogel [Suisse] ; F. Kolbinger [Suisse] ; G. Bruin [Suisse] ; P. Lloyd [Suisse]SAT0142 Immunogenicity of the Novel Anti-Il-17A Antibody, Secukinumab, with Intravenous and Subcutaneous Dosing Regimens in Healthy Subjects and Patients
000660 (2013) M. C. Vieira [États-Unis] ; G. Wallenstein ; J. Bradley ; D. Gruben ; T. Koncz [États-Unis] ; S. H. Zwillich ; J. P. Jansen [États-Unis]SAT0115 Tofacitinib Versus Biologic Treatments in Patients with Active Rheumatoid Arthritis Who have had an Inadequate Response to Tumour Necrosis Factor Inhibitors - A Network Meta-Analysis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "sat" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "sat" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    sat
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021